Gastro-oesophageal reflux is a common complaint in the adult population. According to Richter and Castell the prevalence of daily heartburn in apparently healthy people is as high as 7%.' In a recent paper Heading reports a prevalence of 5% for heartburn in the Western adult population,2 whereas a prevalence of 12% was found in a Danish survey. 3 The prevalence of gastro-oesophageal reflux without oesophagitis has been estimated to be approximately 50% greater than that of oesophagitis,4 though it has recently been suggested that oesophagitis is the most frequent pathological finding in patients submitted to upper gastrointestinal endoscopy in general gastroenterological practice. 2 Despite the high frequency of reflux without oesophagitis, knowledge of its epidemiology and natural history is limited, mainly because of inconsistency in terminology and diagnosis, as pointed out by others.25 As far as diagnosis is concerned, however, the recent availability of methods for extended oesophageal pH monitoring has made it possible not only to define objectively the presence of reflux, relating it to the patient's symptoms, but also to evaluate the degree of acid exposure of the oesophageal mucosa.
The aims of our study were to ascertain (i) whether in patients with pathological reflux but no oesophagitis medical treatment with antisecretory drugs is effective in achieving symptom control and in preventing the development of erosive changes, and (ii) whether severe pretreatment reflux may be associated with an unfavourable outcome.
Methods
The study consisted of the retrospective analysis of 33 outpatients referred to our unit from January 1987 to December 1988 for typical symptoms of gastro-oesophageal reflux -heartburn or regurgitation, or both -and who had a negative oesophagoscopy but had evidence of pathological reflux as assessed by pH-metry. Demographic, clinical, and endoscopic features of the patients are given in Table I (n=5) or absence (n=28) oferosive cha 3 and 4). Average total % reflux time i and 11-7% in the two groups re (p>O0O5). Finally, the pH monitorin :0 reflux before and after treatment in the five patients developing oesophagitis are shown in Figure 5 . Again, despite substantial individual fluctuations, average % reflux time did not change from before treatment to after treatment either during the daytime (16-3% v 8 8%) or during the night (11F2% v 9-3%; p>0 05). The median follow up period for the 14 patients who were asymptomatic after the treatment period was eight months. During this interval none of the patients presented symptomatic relapses of more than one week's duration and were therefore considered to be in remission.
Discussion
Data on the natural history of pathological reflux without oesophagitis are scanty and outdated. Reports in the 1960s and 1970s"o suggest overall a benign outcome in most patients, with symptoms disappearing rapidly after diagnosis, even in the absence of treatment: according to these studies, therefore, clinical improvement is common, even with modestly effective or no medical treatment, and also in severe cases of oesophagitis. In the patients investigated in these surveys, however, pathological gastro-oesophageal reflux was not diagnosed by means of pH monitoring, whereas this technique, which is at development present considered standard, is now widely available. Furthermore, these follow up studies did not include endoscopic control in the evaluation ofthe patient. Finally, we have reported" that 15 mnges (Figs patients with symptomatic and uncomplicated was 14-4% reflux, who were followed up for 12 months after -spectively symptoms disappeared after eight weeks of treatig data for ment with a prokinetic drug (domperidone 20 mg three times a day) or ranitidine (150 mg twice a day), showed a 20% symptomatic relapse rate during a one year follow up without treatment. In all cases newly developed endoscopic oesophagitis was found. We therefore undertook this retrospective analysis to assess whether symptomatic gastrooesophageal reflux patients without mucosal damage will favourably respond to three to six months of treatment with antacid or prokinetic drugs, or both. These drugs were expected to exert a positive effect on symptoms'2 without interfering with the course of the reflux, as documented by our previous observation, in patients with reflux disease but without oesophagitis, that after stopping treatment symptoms may disappear despite persisting acid reflux." As it turned out, only 14 of the 33 patients became completely symptom free after completing treatment, whereas in the remaining 19 pretreatment reflux % was not significantly higher than that in the remaining 28 patients (14-4% v 11 7%).
Finally, we compared the pretreatment and post-treatment duration of reflux in the five patients who developed oesophagitis during treatment. Again, no significant differences were found between the two (16-3% v 8 8%), indicating that the initial severity ofreflux is not directly related to the subsequent course of the disease. It is interesting that during the follow up period all 14 patients who became asymptomatic remained symptom free, even ifactive treatment was being discontinued.
We can affirm that conventional treatment with antacids or prokinetic agents, or both, failed completely to abolish symptoms in a substantial proportion of patients without oesophagitis but with gastro-oesophageal reflux disease as objectively defined by pH-metry studies. In particular, progression to a more severe clinical form of reflux disease was observed in five of 33 patients. Lastly, the degree of acid exposure time before treatment is of no value in identifying patients who will have an unfavourable symptomatic response to medical treatment. A more aggressive initial policy of treating patients with reflux (H2 receptor antagonists or diet and anti-reflux measures, or both) is therefore probably required.
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